A 61-year-old man with metastatic non-small cell lung cancer presents to an outpatient oncology clinic for a scheduled chemotherapy infusion. The oncologist reviews the patient's chart and enters an order for intravenous cisplatin. Ten minutes later, the clinical pharmacist reviewing the order notes that the patient's comprehensive metabolic panel, drawn that morning, shows a serum creatinine of mg/dL, which is a significant increase from his baseline of mg/dL one month ago. Recognizing that cisplatin is highly nephrotoxic and contraindicated in the setting of acute kidney injury, the pharmacist immediately pages the oncologist. The oncologist acknowledges the oversight, cancels the cisplatin order, and prescribes an appropriate, non-nephrotoxic alternative regimen. The patient receives the alternative chemotherapy without any complications. Which of the following best classifies this safety event?
- AActive error
- BPreventable adverse event
- Near missAnswer
- DSentinel event
- EUnpreventable adverse event